Baxter Heparin Recall and Other Heparin News

Heparin Deaths vs. Rat Vomit, Which is Worse?

2009-01-30T22:00:00.000-08:00

Ugh. I don’t which is worse.

Pfizer has a commercial warning consumers not to buy drugs from websites because the ingredients are unknown. Scary? Yes.

But what about real mega-million deep-pockets pharmaceutical companies whose main ingredients come from China and other non-English speaking countries and they still don’t know what or how these main ingredients are made?

This is not fiction. Heparin, the blood thinner, was made from adulterated heparin produced in unregulated Chinese factories.

So far 103 victims have died from the heparin crisis and Baxter is being sued for consumer fraud.

Maybe vomiting up a rat isn’t so bad if you’re still standing when it’s over?

The FDA cannot even regulate Georgia made peanut butter. How can they regulate China?

Heparin: What are the safer alternatives?

2008-12-26T01:45:00.000-08:00

In terms of anticoagulants, Heparin has literally ruled the roost for over 70 years, being the most popularly prescribed drug used in hospitals. In 2007, the medical world received a jolt when the product was recalled due to contamination. Since then, allegations and reports have been surfacing about the FDA's failure to inspect the pharmaceutical plant set-up in China. There have also been 785 serious injuries and 81 deaths as a result of the contaminated drug.

Naturally many people are now looking for an alternative to Heparin. The good news is that researchers are already on the job. After all, the increase in an elderly population as well as vascular intervention means that there should be more anticoagulants available in the market.

Lepirudin is one such alternative which has proven to be effective in treating patients with HAAb. It was also approved by the FDA for the treatment of HIT, though it has also proven to be effective in renal replacement therapy and cardiopulmonary bypass surgery.

Warfarin Sodium is an anticoagulant that can be taken orally but it has a number of risks, including hemorrhaging at certain concentrations. It also requires frequent monitoring. Another oral alternative is Ximelagatran which seemed to be very effective but has since been withdrawn due to issues with toxicity. Researchers are currently looking into direct thrombin inhibition as a method of anticoagulation. In any case, it is just a matter of time before an alternative is found.

Hopefully, patients won't have to deal with issues like the Heparin fiasco in future.

Study Confirms Contaminated Heparin Problem

2008-12-12T09:52:00.000-08:00

The New England Journal of Medicine (NEJM) recently published an article about a study done by Centers for Disease Control and Prevention (CDC) that the heparin recall was justified as it was contaminated with oversulfated chondroitin sulfate (OSCS).

The study focuses on more than 150 adverse reactions to the contaminated heparin. The adverse reactions included shortness of breath, hypotension, and nausea and happened within 30 minutes of taking the heparin.

If you or a loved one have experienced adverse side effects or died from contaminated heparin, contact a wrongful death lawyer immediately before the statute of limitations run out.

FDA Seizes More Heparin

2008-11-29T13:57:00.000-08:00

November 6, 2008—The FDA seized 11 lots of heparin from Celsus Laboratories Inc. in Cincinnati, Ohio.

Five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium were seized by U.S. Marshals. The seized products were manufactured from material imported from China and were contaminated with over-sulfated chondroitin sulfate, a cheaper substance that mimics heparin's anticoagulant activity.

Heparin is a blood-thinning drug. Celsus has distributed Heparin Sodium USP and Heparin Lithium to manufacturers in both the United States and abroad.

Over-sulfated chondroitin sulfate has been linked to multiple adverse events and deaths initially reported to the FDA in January 2008. Since then, the FDA has put in place a comprehensive inspection and import controls program and has acted to remove from the market heparin materials and products with the cheap substitute.

The FDA has initiated 13 recalls of multiple contaminated medical products containing heparin from several companies.

The FDA informed Celsus Laboratories twice that the company's actions to notify customers about a contaminant in its heparin were insufficient to assure an effective recall.

Tainted Heparin Recalls Spurs FDA in China

2008-11-23T20:40:00.000-08:00

Earlier this year, the FDA discovered that contaminated heparin, a blood thinner manufactured in China, had been linked to dozens of deaths. The heparin was laced with a contaminant that mimics real heparin. Several Toledo residents filed wrongful death lawsuits.

Other problems with food and drugs imported from China included pet food, milk products, candy, pet food, and toys with lead. Is China trying to poison us?

What is way overdue but finally happened is that the FDA opened its first office in Beijing after all this contamination. Much more stringent oversight is needed.

More FDA offices will open in Guangzhou and Shanghai plus subsequent locations will include India, the Middle East, Latin America and Europe. FDA employees would inspect products and develop liaisons with Chinese officials and groups.

Heparin and the China Connection

2008-10-28T13:32:00.000-07:00

The pharmaceutical company Baxter International was recently forced to recall Heparin.

This drug, which is used as a blood-thinner, has already gained quite a degree of infamy. It has been linked with a number of overdose cases in infants, several of which have ended in death.

The most famous of these cases involved the children of Hollywood actor Dennis Quaid. Now reports are surfacing about the conditions in which this drug was made. Sources claim that Heparin was manufactured in China, in a factory which US regulators have recently labeled as having objectionable conditions.

While the FDA is currently investigating, they are still unclear as to whether the Chinese plant is the true source of the problems or not. But perhaps more disturbing is that the FDA didn't inspect the plant at all, even before granting the approval. Why? They mixed up the company name with another one.

The FDA is currently looking into a total of 448 cases related to this troublesome drug Heparin. However, only 215 of these cases have been listed as events of interest. In order to avoid a shortage of blood-thinner in the market, APP Pharmaceuticals has increased the production in order to meet the market needs.

Baxter International seems to have landed in hot water in some other areas as well: A number of violations were found at the company's plant in Puerto Rico, including inadequate testing of irradiation equipment. Baxter has already agreed to pay a fine of $15,000.

Heparin and the Hollywood Connection

2008-10-21T13:27:00.000-07:00

Heparin is an anti-coagulant drug often administered to newborn babies in order to prevent clotting in both the body and the IV lines.

Heparin gained notoriety for the role it played in a number of overdose cases. In 2006, six children were given an overdose in Indiana and three of them didn't survive. In Texas, 17 premature babies overdosed as well.

The sobering truth is that Heparin overdose cases seem to have become quite commonplace.

Heparin gained heightened fame when actor Dennis Quaid sued Baxter Healthcare Corp. for negligence when his two babies were given a heparin overdose. They were given 1,000 times the amount they should have received. Luckily, they survived.

Who is to blame?

Some say that it's the drug manufacturer fault, since Heparin packaging is strikingly similar to that of another drug called Heplock. The similar labeling has caused many overdose issues, since both have similar vials with the same kind of coloring. At a glance, it is difficult to tell the two apart.

Others blame the hospital for negligence saying their staff was not trained adequately. The hospital has now taken preventive steps to ensure that this kind of error doesn't happen again.

Quaid used his celebrity status to help bring the Heparin matter to light. Though his experience with Heparin is not a unique one, it does show how lethal the problem really is.

The Trouble with Heparin

2008-10-13T16:09:00.000-07:00

Heparin has caused a major scare in the market

There are a number of problems inherent with taking the drug heparin. These problems are not minor. In fact, the problems associated with the drug present the potential for major side effects. Many people who have taken this blood thinner have felt serious adverse reactions. These reactions include dangerous situations as internal bleeding and even instances of fatalities. This is why the manufacturer Baxter is facing serious consequences in the form of civil actions. However, while it is definitely wise that anyone suffering from any adverse reactions should seek legal remedy it is also important to seek immediate medical help as well.

Even if you have not experienced any immediate adverse reactions to the drug, it is still wise to discuss the matter with your primary care doctor. Just because you may not feel any symptoms from the drug, this does not mean severe negative effects are not occurring. The only way to make sure that you are in perfect shape would be to have your doctor perform a proper examination. It’s important to inform the doctor of how much heparin you have taken and for how long.

Additionally, the level of the severity of the adverse reactions would play a huge role in a civil suit judgment. A doctor's report noting the serious adverse side effects a patient has suffered will surely be needed in court to make a case. Before even getting to this point, it is critical that a patient recover his/her good health. Doing so will aid in eliminating any further serious health dangers. Check with your doctor first and then take the necessary legal steps if needed. This would be the best course of action. Remember….it is health first and legal recourse regarding heparin immediately thereafter.

Reining in Heparin in Hospitals

2008-10-08T19:52:00.000-07:00

According to a regulatory group, hospitals must rein in heparin mistakes by using preventative measures of new bar code technology and computerized drug orders. Recent errors include overdoses to newborn infants including actor Dennis Quaid’s twins.

Now investigators will make surprise visits to ensure that hospitals are using the safety measures. Hospitals who fail will have their accreditation pulled.

The investigators are a private group that sets hospital standards and accredits hospitals and medical centers.

Almost 60,000 medication errors involving blood thinners were reported between 2001 and 2006.

Tainted Baxter Heparin Love

2008-10-01T20:43:00.000-07:00

The cause and effect of Baxter heparin is that three of ten patients tested positive for oversulfated chondroitin sulfate, the contaminant in Baxter heparin. Ten people died and the three of them were the result of a certain numbered lot of Baxter heparin. Heparin lot numbers were not known for the other seven patients

During the first quarter of 2008, 93 deaths were related to heparin.Baxter recalled the heparin products in February 2008 because of the spike in the number of the allergic reactions. It is believed that the oversulfated chondroitin sulfate was put intentionally in heparin by suppliers in China. Prior to this latest Baxter recall, the company received heparin's active ingredient from U.S. based Scientific Protein Laboratories. Heparin's active pharmaceutical ingredient is derived from pig intestines.

Earlier this year, the FDA tallied more than 90 reports of deaths and more than 1,000 adverse events associated with patients in the U.S. who had one or more allergic reactions to heparin products, including those sold by Baxter since Jan. 1, 2007. Clinical information is insufficient to specify the cause of death with clinical certainty.

Trouble with Heparin

2008-09-26T13:29:00.000-07:00

Heparin has caused a major scare in the marketplace

There are a number of problems inherent with taking the drug heparin. These problems are not minor. In fact, the problems associated with the drug present the potential for major side effects. Many people who have taken this blood thinner have felt serious adverse reactions. These reactions include dangerous situations as internal bleeding and even instances of fatalities. This is why the manufacturer Baxter is facing serious consequences in the form of civil actions. However, while it is definitely wise that anyone suffering from any adverse reactions should seek legal remedy it is also important to seek immediate medical help as well.

Even if you have not experienced any immediate adverse reactions to the drug, it is still wise to discuss the matter with your primary care doctor. Just because you may not feel any symptoms from the drug, this does not mean severe negative effects are not occurring. The only way to make sure that you are in perfect shape would be to have your doctor perform a proper examination. It’s important to inform the doctor of how much heparin you have taken and for how long.

Additionally, the level of the severity of the adverse reactions would play a huge role in a civil suit judgment. A doctor's report noting the serious adverse side effects a patient has suffered will surely be needed in court to make a case. Before even getting to this point, it is critical that a patient recover his/her good health. Doing so will aid in eliminating any further serious health dangers. Check with your doctor first and then take the necessary legal steps if needed. This would be the best course of action to employ bar none. Remember….it is health first and legal recourse regarding heparin immediately thereafter

heparin and kidney dialysis problems

2008-09-21T14:51:00.000-07:00

There are a number of problems heparin causes during kidney dialysis treatment.

It would be difficult to think of many more difficult medical situations to endure than kidney dialysis. To be blunt, kidney dialysis is used to save people's lives. Kidney dialysis is necessary when the kidneys are not functioning properly. Obviously, the kidneys are critical organs and if they do not function properly then there is the possibility for a life threatening scenario to develop. This is why kidney dialysis should not be made more complicated by the presence of other medical problems. As a result, other medications are brought into the picture to help stabilize the dialysis process. This is where heparin comes into play.

Heparin is an intravenous blood thinner used in conjunction with kidney dialysis. It is a major component in making sure the dialysis process works effectively. It’s nothing short of absolutely frightening when there is a problem with the drug. And, yes, a problem with the drug has developed. There have been a number of adverse reactions to heparin that range from severe allergic reactions to death as a result of taking heparin which has led to the FDA issuing a warning.

Issuing a warning hardly leaves the manufacturer, Baxter, off the hook for any adverse reactions deriving from heparin use. Nothing will absolve Baxter from any judgments from the heparin lawsuits that emerged in the aftermath of the warnings. The release of a dangerous drug is a very negligent action on the part of the manufacturer.

So, if you have suffered any adverse effects from taking heparin you may have a strong case for a lawsuit. That is why it is critical to discuss your options with a qualified attorney who can handle litigation against pharmaceutical companies. While these types of lawsuits are complex, they are not unwinnable as many huge judgments prove.

Heparin: How much is enough?

2008-09-17T02:34:00.000-07:00

According to the FDA, over one million doses of heparin were ingested by people who require use of the blood thinning medication. While one would assume that this would be a safe product since it is taken by so many people, the fact remains that this is a very dangerous drug. In fact, a number of fatalities have been reported. This is why a series of warnings has been issued by the FDA.

However, this brings about the question why is heparin such a dangerous product?

This question takes on a unique dimension when it is revealed heparin has been on the market for 70 years. Yes, you read that correctly. Heparin has been on the market for seven decades. How to the drug become so dangerous in only recent memory?

It is possible that there had been a number of problems with heparin in the past that have gone unnoticed, but this would be very unlikely. When you are talking about 70 years and millions of doses clearly a dangerous product would have revealed itself in the past.

Currently, the reasons behind the dangers of heparin are unknown and an investigation is under way. Hopefully, this investigation will reveal the reason why new product has become so harmful. From this, the ability to prevent such an incident from occurring in the future will be reduced.

At the present time, one needs to suffice with the cryptic warning as it is more important understand the clear and present danger as opposed to the reasons behind it.

Will the warnings of lawsuits associated with a heparin errode public confidence in the pharmaceutical companies? To a slim degree, it will. There, most people do realize that these types of problems are an anomaly and generally pharmaceutical drugs are safe and improve the quality of life.

FDA Investigating Heparin Drugs and More

2008-09-07T21:19:00.000-07:00

No Worries: FDA Investigating 20 Different Drugs Including Heparin

Leave it to the Food & Drug Administration to be investigating 20 different drugs for safety concerns but to not pull them off the market.

Nope, it's big business as usual. Keep taking them and building the fortunes of the pharmaceutical companies.

Heparin is one of those drugs as is Cymbalta for depression and a type of insulin among others.

Recommendations are to continue to take the drug and do not stop abruptly unless under a doctor's care. Your doctor should help you weigh the risks against the benefits.

Heparin: Purposeful Poisoning or Accidental?

2008-08-24T21:45:00.000-07:00

Was the latest heparin blood thinner debacle purposeful or an accident?

Usually conservative in opinion, the FDA commissioner told a Senate subcommittee that the heparin contamination was an economic fraud. The heparin contaminant of oversulfated chondroitin sulfate costs $9 a pound compared with $900 a pound for the active ingredient heparin.

Contaminated heparin-induced 81 deaths is being compared to cyanide laced Tylenol. However, with the blood thinner heparin there were far more deaths including a 60ish man in Ohio who lost both his wife and his son because they both suffered from the same genetic kidney disease that required constant dialysis.

The FDA has identified Changzhou SPL, a Chinese subsidiary of Scientific Protein Laboratories, as the source of the contaminated heparin. Chinese officials dispute the FDA that the contaminant caused injuries and death.

The FDA failed to inspect the plant as did Changzhou SPL. The FDA claims they don't have the budget to properly inspect all the foreign drug inspections.

Nobody wants to get tapped on the shoulder with heparin death blame. So what else is new? Who's minding the store?

Heparin Debaucle and the FDA

2008-08-23T12:30:00.000-07:00

When there is a drug or food blunder in another country, that country reacts and immediately recalls the offensive product. The same cannot be said about the FDA and the United States. The FDA doesn't have the power to do so but can only recommend a recall or black box warning label which usually takes months to implement.

In the meantime more people are seriously and fatally affected.

Like in the case of the blood thinner heparin -- In the Heparin debacle, the FDA reported that since the end of 2007, it received over 700 reports of adverse side effects associated with Baxter’s multiple-dose injectable Heparin; 40 percent of these reports were deemed serious.
There were inadequate FDA inspections of overseeing the active ingredients obtained from unregulated factories in China.

In the meantime, the FDA executives are giving themselves huge pay raises while there is no money in the budget to effectively monitor and investigate imports from other countries or hire more employees.

Heparin Testing Goes Awry?

2008-08-18T09:35:00.000-07:00

Did flawed heparin tests lead to the recall?

If the primary purpose of heparin it is to make life better for those who take it why did the drug turn out to be so dangerous? Wouldn't the manufacturer, Baxter, realize that releasing a dangerous drug into the marketplace would cause so many problems? Honestly, Baxter did not release purposefully release a dangerous drug in the marketplace. However, the release of the drug heparin was seriously flawed due to improper lab testing. This places a great deal of negligence on Baxter's shoulders.

Let's look at the situation more closely…

When numerous adverse side effects started to display themselves in patients who had been taking heparin, the FDA conducted an examination of the drug to ascertain the problem. As it turned out, the drug contained a dangerous contaminant. It was this contaminant that was the reason a great many people were suffering serious adverse side effects. And, needless to say, this was the reason the drug was pulled off the market. Proper testing of the product would have revealed this contaminant, but the tests conducted were weak. Now, while it was not Baxter's intention to release a dangerous product to the public this is exactly what the company did. Of course, this is also why the company is being held liable for the damages that have resulted in the aftermath of the release.

It is the responsibility of all pharmaceutical companies to make sure that any products that are released to the marketplace are safe for consumers. Often, consumers rely on these products for their very lives. This is why it is important that the product itself does not threaten the life of the person taking it. Yet, this is exactly the problem with heparin. Baxter was responsible for properly conducting tests to make sure this was a safe drug. Obviously, this is not the procedure the company followed and this is why Baxter is in the position it finds itself in right now.

Safer Synthetic Alternative to Contaminated Heparin

2008-08-17T18:48:00.000-07:00

The main source for heparin is the intestines of foreign livestock.

Disgusting!

The intestines of foreign livestock creates a condition that is wide open for mass contamination which recently happened in the latest China heparin catastrophe.

A team at the University of North Carolina developed synthetic heparin in 2006 and has worked since that time to fine tune a safer and better version of the blood thinner heparin. Oddly, the backbone for the new heparin comes from the bacteria found in e.coli which is easier to produce.

Through a proprietary scientific process it will probably take around five years to produce the demand required and go through clinical trials.

Better living with chemistry.

Good news, bad news, raw material, heparin

2008-08-13T11:12:00.000-07:00

In a global economy, there is both good news and bad news.

The good news is the possibility to increase economies of scale as well as breaking down barriers allowing companies to benefit from the largest and cheapest workforces, raw materials, and technology.

That's also the bad news.

Where's the quality control? Who's minding the store and the regulatory problems?

A perfect example is heparin.

The active ingredient is made in China without any regulatory oversight. The US Federal Drug Administration (FDA) doesn't have a handle on it and neither does its Chinese equivalent.

More than 50 percent of drug active ingredients are produced in China and India. Who's paying attention?

In regard to heparin, the FDA admitted to insufficient inspection of an American-owned production facility in China, prior to approving the drug for market.

On the good news side, a permanent FDA office is scheduled to open in China by October 2008 and pharmaceutical manufacturers there will be subjected to stricter scrutiny.

What about India?

Unfortunately, it's too late for the people who have already died from heparin.

Heparin – Class Action or Go It Alone?

2008-08-09T09:32:00.000-07:00

Is a class action heparin suit better than a "solo" suit?

If you have suffered as a result of taking heparin, you may be thinking of taking legal action. This is understandable because may of the severe consequences of taking this drug are the result of negligence on the part of the manufacturer. The manufacturer, Baxter, truly did not properly test and produce this potentially hazardous blood thinner. This is why there are a number of suits pending against Baxter. Those currently looking to file suit, however, many not be sure of what type of suit to file

That is, they may not know whether or not to file an action on their own or to take part in a class action lawsuit. For those not familiar with the term, a class action lawsuit is essentially a collective action were the multitude of people act as the plaintiffs in the suit. If a heparin settlement or judgment is arrived the monetary award would be the split among the various plaintiffs.

This, of course, brings about the question as to what would be the best course of action to take, filing a solo or class action suit. Honestly, this is not a question that can be answered with absolutism because each litigant's situation is different. Different needs and personal situations will dictate the proper course of action to take. So, in order to arrive at a decision, it would be best to consult with an attorney. In such a meeting, the various positives and negatives of class action vs. solo suits can be discussed.

They may be better served with an individual suit. Ultimately, the client needs to realize what would be the right action to take and careful deliberation with an attorney will aid in this regard.

FDA questions labeling of blood drug therapy

2008-08-08T13:13:00.000-07:00

Tainted Heparin, a blood thinner medication, manufactured by Baxter International has been directly linked to the deaths of three people as reported previously on this Baxter heparin recall blog.

Most recently, the FDA criticized Baxter International for misleading doctors about FEIBA VH's safety. FEIBA VH is a bleeding treatment drug therapy for people with hemophilia.

The FDA criticized the statement:

"FEIBA is well tolerated in 96%-100% of infusions with a low thrombotic event incidence (0.008%)"

According to the FDA, this is exaggerated.

The FDA requested that Baxter immediately cease the dissemination of the offending email letter as well as any same as or similar violative promotional materials for FEIBA VH.

Death by Heparin: The Responsibility Lies With...

2008-07-30T13:40:00.000-07:00

According to an article in the Chicago Tribune, the FDA conclusively linked patients deaths to specific lots of Baxter International heparin.

Of 10 deaths from severe hypotensive shock, three were traced to lot numbers of Baxter products that tested positive for oversulfated chondroitin sulfate.

Baxter recalled its heparin products in February when the number of allergic reactions spiked. Health officials and Baxter believe that the contaminated heparin was done intentionally by Chinese suppliers.

Chinese health officials continue to question whether the problems may have originated elsewhere. The Chinese maintain the problems did not originate with active ingredient sourced in China despite analysis by FDA, Baxter and outside experts.

93 people died in a short three month period; that's one a day. The FDA needs to continue investigating why. The families deserve to know.

If your loved one has died because of heparin tragedy, please contact Anapol Schwartz, a Pennsylvania personal injury law firm.

Hunt for Heparin Continues

2008-07-29T13:59:00.000-07:00

Calling all nurses!

The Georgia Association of Nurse Anesthesists (GANA) put out a FDA alert asking nursing professionals to be on the lookout for the continued use of oversulfated chondroitin sulfate contaminated heparin products.

And to report any adverse heparin related side effects.

Despite all the heparin recalls, the FDA believes that some heparin blood thinner products are still in use. Health professionals are urged to check out drug storage areas, emergency kits, and dialysis units.

Please educate yourself and other nurses about the problems associated with heparin usage.

The Herparin Recall

2008-07-29T09:22:00.000-07:00

A look into the Heparin recall is provided.

The Food and Drug Administration does not issue recalls without cause. This is because there are a number of problems inherent with issuing a recall flippantly. For example, issuing a recall can lead to a great deal of panic in the marketplace. This panic can seriously undermine the public's confidence in the safety of drugs. However, in the case of heparin, a recall was unavoidable.

It is not the goal of the FDA to scare people into believing that their medications are not safe unless sufficient cause is warranted. When a clear danger is present, however, the Food and Drug Administration will be quick to act in order to maintain a desired level of safety in the pharmacy world. Such was the case with Baxter's Heparin which turned out to be a product that was far less safe than what was originally believed.

The original intent of the drug was to act as a blood thinner. Unfortunately, there were a number of serious side effects associated with the use of this drug. These were not minor side effects as instances of serious injury and even death were reported. Of course, this led to many wondering how such flaws could be present in the medication. Eventually, it was revealed the actual physical production of the drug took place in China. As many news reports have shown, China is not exactly a country that puts much emphasis on the safety of its products. Such negligence found it's was into the process of producing heparin. But, regardless of where the drug was produced it is Baxter's responsibility to make sure that it is releasing a safe product in the market. Baxter failed in this regard and that is why it is facing the consequences of such non-action.

Currently, Baxter is facing a number of civil suits as a result of the heparin fiasco. While these suits can not change the past they can make sure that the future releases of such drugs are not rife with such serious problems. Hopefully, those who have filed suit will receive just compensation for the mishaps they have had to endure.

Probe continues in infants heparin overdose

2008-07-27T21:21:00.000-07:00

Medical and pharmaceutical personnel are being deposed in the case of families whose newborns received overdoses at a Corpus Christi hospital.

Temporary restraining orders were also extended in order to preserve medical records related to the two sets of twins who were among the 17 newborns receiving the overdoses of the blood thinner heparin.

An agreement was reached that the hospital would release to the plaintiffs samples of the batch of heparin given to the newborns.

The plaintiffs sought the temporary injunction to find out information about the drug's manufacturer.

Twins born July 1 died in July. For twins born June 16, one newborn died and the other remains in neonatal ICU.